Atsena Therapeutics

BiotechDurhamSeries C

atsenatx.com

Gene therapy for inherited retinal diseases

At a glance

HQ: Durham
Sector: Biotech
Stage: Series C
Total raised: $213.2M
Last round: Series C

Open roles

All open Triangle roles

Associate Director or Director, Regulatory Strategy (Clinical & Nonclinical)

RemoteRemote

Senior Director, Medical Affairs

RemoteRemote

Senior Manager, Clinical Quality Operations

RemoteRemote

The rest of this record is behind a free account.

Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.